Open AccessA Randomized Pilot Study of Donor Stem Cell Infusion in Living-Related Kidney Transplant Recipients Receiving Alemtuzumab
Author(s) -
Gaetano Ciancio,
Junichiro Sageshima,
Ersin Akpınar,
Jeffrey J. Gaynor,
Linda Chen,
Alberto Zarak,
Lois Hanson,
Lissett Tueros,
Giselle Guerra,
Adela Mattiazzi,
Warren Kupin,
David Roth,
Camillo Ricordi,
George W. Burke
Publication year - 2013
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0b013e3182a0f68c
Subject(s) - medicine , alemtuzumab , immunosuppression , tacrolimus , surgery , regimen , weaning , sirolimus , transplantation , biopsy
Transplant tolerance would remove the need for maintenance immunosuppression while improving survival and quality of life.